Latest Acquisition Disputes News

Mayne Pharma has received $14.4 million from Cosette Pharmaceuticals covering legal costs and interest following a Supreme Court ruling in its favour. The legal battle continues with Cosette’s appeal decision pending.

Mayne Pharma has received notice of Cosette Pharmaceuticals' intention to appeal a court ruling in their acquisition dispute, potentially delaying the proposed takeover. The legal saga continues as key approvals and hearings loom.

Mayne Pharma reported a 5% revenue increase to $408.1 million for FY25 but posted a net loss of $93.8 million, narrowing from the prior year. The company’s planned acquisition by Cosette Pharmaceuticals faces legal hurdles, delaying completion.

Robex Resources has successfully listed on the ASX, raising A$120 million to fund its Kiniéro Gold Project in Guinea, which remains on track for first gold production in late 2025. Meanwhile, steady output continues at its Nampala Mine in Mali despite rising costs.

Carawine Resources Limited has progressed exploration planning across key Australian projects while navigating a significant compulsory acquisition dispute initiated by major shareholder QGold.